Peroxisome proliferator-activated
receptor alpha (PPARα) is a member of the nuclear receptor family of
ligand-activated transcription factors that heterodimerize with the
retinoic X receptor (RXR) to regulate gene expression. PPARα is located
primarily in the liver, adipose tissue, kidney, heart, skeletal muscle
and large intestine where it is thought to regulate fatty acid synthesis
and oxidation, gluconeogenesis, ketogenesis and lipoprotein assembly.
The human gene encoding PPARα has been localized to chromosome 22
(22q12-13.1).
Species Gene Symbol Gene Accession No. Protein Accession No.
Human PPARA NM_001001928 Q07869
Mouse Ppara NM_011144 P23204
Rat Ppara NM_013196 P37230
抑制劑
GW 6471
分子量:635.68 分子式:C35H36F3N3O5
Solubility:Soluble to 100 mM in DMSO and to 100 mM in ethanol
Purity:>98 % 10mg ,50mg 規格
CAS No:[436159-64-7]
Chemical Name:[(2S)-2-[[(1Z)-1-Methyl-3-oxo-3-[4-(trifluoromethyl)phenyl]-1-propenyl]amino]-3-[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]propyl]-carbamic
acid ethyl ester
Sold with the permission of GlaxoSmithKline 過氧化物酶增殖活化受體α抑制劑 GW6471 PPARα 系列產品
PPARαantagonist that inhibits activation with an IC50 value of 0.24μM.
MK 886
分子量:472.08 分子式:C27H34ClNO2S
Solubility:Soluble to 5 mM in ethanol and to 100 mM in DMSO
Purity:>98 % 10mg ,50mg 規格
Storage:Store at RT
CAS No:[118414-82-7]
Chemical Name:
1-[(4-Chlorophenyl)methyl]-3-[(1,1-dimethylethyl)thio]-α,α-dimethyl-5-(1-methylethyl)-1H-Indole-2-propanoic
acid
別名:L-663,536
An inhibitor of leukotriene
biosynthesis (IC50 = 3 nM in human polymorphonuclear leukocytes). Acts
by inhibiting 5-lipoxygenase-activating protein (FLAP) (IC50 = 30 nM for
inhibition of [125I]-L-691,678 photoaffinity labelling). Also
moderately potent PPARαantagonist (IC50 = 0.5-1μM). Orally activein vivo.
激動劑
GW 7647
分子量:502.75 分子式:C29H46N2O3S
Solubility:Soluble to 25 mM in ethanol and to 100 mM in DMSO
Purity:>99 % 10mg ,50mg 規格
CAS No:[265129-71-3]
Chemical Name: 2-[[4-[2-[[(Cyclohexylamino)carbonyl](4-cyclohexylbutyl)amino]ethyl]phenyl]thio]-2-methylpropanoic acid
Potent and highly selective PPARαagonist (EC50 values are 6, 1100 and 6200 nM for human PPARα, PPARγand PPARδreceptors respectively). Modulates oleate metabolism and mitochondrial enzyme gene expression in mature myotubulesin vitro. Has lipid-lowering effects following oral administrationin vivo. Reduces NO production in macrophages; exhibits anti-inflammatory properties